Urogen Pharma Ltd. · NASDAQ:URGN
Smith Jason Drew sold 1,519 Urogen Pharma Ltd. shares (Form 4)
Traded Sep 7 to Sep 8, 2026 · Filed Sep 9, 2026
From Sep 7 to Sep 8, 2026, Smith Jason Drew (General Counsel) sold 1,519 Urogen Pharma Ltd. shares at US$42.54 for US$64,618, leaving 53,141 shares. Filed Sep 9, 2026 (Form 4).
- Sold
- 1,519 shares
- Price
- US$42.54
- Value
- US$64,618
- Holding after
- 53,141 shares
- Trading plan
- No
- Role
- General Counsel
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 7, 2026 | Ordinary Shares | Option exercise | 3,334 | 54,660 | Direct | |
| Sep 8, 2026 | Ordinary Shares | Sale | 1,519 | US$42.54 | 53,141 | Direct |